|
|
||||||||
J Thorac Cardiovasc Surg 1998;116:949-953
© 1998 Mosby, Inc.
GENERAL THORACIC SURGERY |
From the Department of Thoracic Surgery, Hyogo Medical Center for Adults, Akashi City, Hyogo, Japan.
Received for publication Jan 26, 1998. Revisions requested March 16, 1998; revisions received July 17, 1998. Accepted for publication Aug 11, 1998. Address for reprints: Noriaki Tsubota, MD, Department of Thoracic Surgery, Hyogo Medical Center for Adults, Kitaohji-cho 13-70, Akashi City 673, Hyogo, Japan.
Objective: The aims of this study were to reveal the characteristics of skipping N2 lung cancer and to develop a more reasonable approach for dissecting mediastinal lymph nodes.
Methods: Of consecutive 956 patients who were operated on for primary lung cancer from 1986 through 1996, 760 (79.5%) had a diagnosis of nonsmall cell carcinoma and were subjected to complete resection of the tumor together with hilar and mediastinal lymphadenectomy.
Results: Of 141 patients with N2 disease, 53 (37.6%) had skipping metastases. Among 78 patients with N2 cancer of the upper lobe, 37 (47.4%) had skipping metastases affecting upper or aortic mediastinal nodes whereas none of them had skipping metastases affecting lower mediastinal nodes. Among 47 patients with N2 cancer of the lower lobe, 13 (27.7%) had skipping metastases affecting mediastinal nodes. Of these 13 patients, 11 (84.6%) had skipping metastases affecting the subcarinal node. The remaining 2 patients had a huge primary tumor.
Conclusions: Dissection of the upper part of the mediastinum including the aortic regions should be performed regardless of the operative appearance when cancer is located in the upper lobe, but it is not required for lower lobe tumors with negative hilar and subcarinal nodes. Dissection of the subcarinal node in patients with an upper lobe tumor is not routinely needed when the nodes in both the hilum and upper mediastinum are intact. We consider that the subcarinal node is of significance and skipping metastases should be defined as metastases that skip the subcarinal node in addition to N1 nodes.
This article has been cited by other articles:
![]() |
S.-i. Watanabe, K. Suzuki, and H. Asamura Superior and Basal Segment Lung Cancers in the Lower Lobe Have Different Lymph Node Metastatic Pathways and Prognosis Ann. Thorac. Surg., March 1, 2008; 85(3): 1026 - 1031. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Muraoka, S. Akamine, T. Oka, T. Tagawa, A. Nakamura, T. Tsuchiya, T. Hayashi, and T. Nagayasu Sentinel node sampling limits lymphadenectomy in stage I non-small cell lung cancer Eur. J. Cardiothorac. Surg., August 1, 2007; 32(2): 356 - 361. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Okada, T. Sakamoto, T. Yuki, T. Mimura, K. Miyoshi, and N. Tsubota Selective Mediastinal Lymphadenectomy for Clinico-Surgical Stage I Non-Small Cell Lung Cancer. Ann. Thorac. Surg., March 1, 2006; 81(3): 1028 - 1032. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Okada, T. Sakamoto, T. Yuki, T. Mimura, H. Nitanda, K. Miyoshi, and N. Tsubota Border between N1 and N2 stations in lung carcinoma: Lessons from lymph node metastatic patterns of lower lobe tumors J. Thorac. Cardiovasc. Surg., April 1, 2005; 129(4): 825 - 830. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-i. Watanabe, H. Asamura, K. Suzuki, and R. Tsuchiya The new strategy of selective nodal dissection for lung cancer based on segment-specific patterns of nodal spread Interactive CardioVascular and Thoracic Surgery, April 1, 2005; 4(2): 106 - 109. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Tiffet, A. G. Nicholson, A. Khaddage, N. Prevot, G. Ladas, F. Dubois, and P. Goldstraw Feasibility of the Detection of the Sentinel Lymph Node in Peripheral Non-small Cell Lung Cancer With Radio Isotopic and Blue Dye Techniques Chest, February 1, 2005; 127(2): 443 - 448. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Riquet, J. Assouad, P. Bagan, C. Foucault, F. Le Pimpec Barthes, A. Dujon, and C. Danel Skip Mediastinal Lymph Node Metastasis and Lung Cancer: A Particular N2 Subgroup With a Better Prognosis Ann. Thorac. Surg., January 1, 2005; 79(1): 225 - 233. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Okada, W. Nishio, T. Sakamoto, K. Uchino, T. Yuki, A. Nakagawa, and N. Tsubota Sleeve segmentectomy for non-small cell lung carcinoma J. Thorac. Cardiovasc. Surg., September 1, 2004; 128(3): 420 - 424. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Keller, M. G. Vangel, H. Wagner, J. H. Schiller, A. Herskovic, R. Komaki, R. S. Marks, M. C. Perry, R. B. Livingston, and D. H. Johnson Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease J. Thorac. Cardiovasc. Surg., July 1, 2004; 128(1): 130 - 137. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Okada, W. Nishio, T. Sakamoto, K. Uchino, T. Yuki, A. Nakagawa, and N. Tsubota Evolution of surgical outcomes for nonsmall cell lung cancer: time trends in 1,465 consecutive patients undergoing complete resection Ann. Thorac. Surg., June 1, 2004; 77(6): 1926 - 1930. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Tanaka, K. Takenaka, H. Oyanagi, T. Fujinaga, Y. Otake, K. Yanagihara, H. Ito, and H. Wada Skip mediastinal nodal metastases in non-small cell lung cancer Eur. J. Cardiothorac. Surg., June 1, 2004; 25(6): 1114 - 1120. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Okada, W. Nishio, T. Sakamoto, H. Harada, K. Uchino, and N. Tsubota Long-term survival and prognostic factors of five-year survivors with complete resection of non-small cell lung carcinoma J. Thorac. Cardiovasc. Surg., August 1, 2003; 126(2): 558 - 562. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sugi, Y. Kaneda, M. Sudoh, H. Sakano, and K. Hamano Effect of radioisotope sentinel node mapping in patients with cT1 N0 M0 lung cancer J. Thorac. Cardiovasc. Surg., August 1, 2003; 126(2): 568 - 573. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M.A. Melfi, A. Chella, G. F. Menconi, F. Givigliano, G. Boni, G. Mariani, P. Sbragia, and C. A. Angeletti Intraoperative radioguided sentinel lymph node biopsy in non-small cell lung cancer Eur. J. Cardiothorac. Surg., February 1, 2003; 23(2): 214 - 220. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-i. Watanabe, M. Oda, Y. Tsunezuka, T. Go, Y. Ohta, and G. Watanabe Peripheral small-sized (2 cm or less) non-small cell lung cancer with mediastinal lymph node metastasis; clinicopathologic features and patterns of nodal spread Eur. J. Cardiothorac. Surg., December 1, 2002; 22(6): 995 - 999. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. E. Schmidt, E. A. Woltering, W. R. Webb, O. M. Garcia, J. E. Cohen, and M. H. Rozans Sentinel nodal assessment in patients with carcinoma of the lung Ann. Thorac. Surg., September 1, 2002; 74(3): 870 - 875. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Okada, K. Yoshikawa, T. Hatta, and N. Tsubota Is segmentectomy with lymph node assessment an alternative to lobectomy for non-small cell lung cancer of 2 cm or smaller? Ann. Thorac. Surg., March 1, 2001; 71(3): 956 - 960. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Tsubota Reply J. Thorac. Cardiovasc. Surg., February 1, 2001; 121(2): 399 - 340. [Full Text] [PDF] |
||||
![]() |
M. J. Liptay, G. A. Masters, D. J. Winchester, B. L. Edelman, B. J. Garrido, T. R. Hirschtritt, R. M. Perlman, and W. A. Fry Intraoperative radioisotope sentinel lymph node mapping in non-small cell lung cancer Ann. Thorac. Surg., August 1, 2000; 70(2): 384 - 389. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Okada, N. Tsubota, M. Yoshimura, Y. Miyamoto, and H. Matsuoka Induction Therapy for Non-small Cell Lung Cancer With Involved Mediastinal Nodes in Multiple Stations Chest, July 1, 2000; 118(1): 123 - 128. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Okada, H. Yamagishi, S. Satake, H. Matsuoka, Y. Miyamoto, M. Yoshimura, and N. Tsubota SURVIVAL RELATED TO LYMPH NODE INVOLVEMENT IN LUNG CANCER AFTER SLEEVE LOBECTOMY COMPARED WITH PNEUMONECTOMY J. Thorac. Cardiovasc. Surg., April 1, 2000; 119(4): 814 - 819. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Okada, N. Tsubota, M. Yoshimura, Y. Miyamoto, and H. Matsuoka How should interlobar pleural invasion be classified? prognosis of resected T3 non-small cell lung cancer Ann. Thorac. Surg., December 1, 1999; 68(6): 2049 - 2052. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Okada, N. Tsubota, M. Yoshimura, Y. Miyamoto, H. Matsuoka, S. Satake, and H. Yamagishi EXTENDED SLEEVE LOBECTOMY FOR LUNG CANCER: THE AVOIDANCE OF PNEUMONECTOMY J. Thorac. Cardiovasc. Surg., October 1, 1999; 118(4): 710 - 714. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Okada, N. Tsubota, M. Yoshimura, Y. Miyamoto, and H. Matsuoka PROGNOSIS OF COMPLETELY RESECTED pN2 NON-SMALL CELL LUNG CARCINOMAS: WHAT IS THE SIGNIFICANT NODE THAT AFFECTS SURVIVAL? J. Thorac. Cardiovasc. Surg., August 1, 1999; 118(2): 270 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Tsubota Reply Ann. Thorac. Surg., May 1, 1999; 67(5): 1541 - 1541. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |